Status:
RECRUITING
Fibrosis Assessment in Myocardial Infarction-associated Ventricular Aneurysm
Lead Sponsor:
RenJi Hospital
Conditions:
Acute Myocardial Infarction
Ventricular Aneurysm Following Acute Myocardial Infarction
Eligibility:
All Genders
18-75 years
Brief Summary
The study will use 18F-FAPI PET/CT to study myocardial fibrosis in patients diagnosed with myocardial infarction-associated ventricular aneurysm (MI-VA). Participants will receive the PET/CT scan duri...
Detailed Description
The aim of this study is to investigate the temporal and spatial distribution of myocardial fibrosis in patients diagnosed with myocardial infarction-associated ventricular aneurysm using the novel fi...
Eligibility Criteria
Inclusion
- Aged 18-75 years old
- Diagnosed with STEMI or NSTEMI (ACC/AHA guidelines)
- Half male and half female
- Undergo CAG and PCI treatment;
- Receive either echocardiography or CMR to identify a ventricular aneurysm;
- Written informed consent
Exclusion
- Patients under the age of 18 years old;
- Patients who are pregnant/breastfeeding;
- Patients who has a previous history of allergy to radio tracers.
Key Trial Info
Start Date :
November 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06994221
Start Date
November 1 2024
End Date
December 31 2025
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji Hospital
Shanghai, China, 200127